Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Toyoake-shi
Clinical trial register · Japan

Clinical Trials in Toyoake-shi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2493 matching records held by the registry are in this view. Synced 22 Oct 2026, 03:19 UTC
2493
Studies in scope
all four open statuses
1263
Recruiting now
open to new participants
349
Lead sponsors
across recruiting studies
Top sites
Fukuoka 551 Nagoya 517 Sapporo 398 Tokyo 369 Osaka 348
Narrow the registerReset
Recruitment status
Phase
Site location
Fukuoka551 Nagoya517 Sapporo398 Tokyo369 Osaka348
All 926 locations
Target enrolment
to

Trials with a site in Toyoake-shi

25 of 2493 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca
Phase 1/2
152
Bunkyō City, Kashiwa, Kurume-shi, Kyoto, Niigata, Shinjuku-ku, Toyoake-shi
2025-11-24
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Kanazawa, Kasugai, Kawasaki-shi, Okayama, Shōwaku, Suita, Toyoake-Shi, Urayasu
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Nagoya-sh, Toyoake Shi, Asahikawa-shi, Suita, Suita-shi, Ōtsu, Chūōku, Fukuoka
2025-09-22
Recruiting
Amgen
Phase 3
12,800
Nagoya, Toyoake-shi, Chiba, Sapporo, Naka, Toride-shi, Tsuchiura-shi, Kanazawa
2025-07-25
Recruiting
Takeda
Phase 3
347
Kasugai-Shi, Nagoya, Toyoake-shi, Chiba, Fukuoka, Fukushima, Hiroshima, Sapporo
2025-07-15
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Toyoake-shi, Chiba, Fukuoka, Kitakyushu-shi, Sapporo, Himeji-shi, Takarazuka-shi, Kanazawa
2025-06-25
Recruiting
Biogen
Phase 3
454
Toyoake-shi, Hirosaki-shi, Chiba, Urayasu-Shi, Sapporo, Kitakyushu-shi, Fukushima, Kawasaki-shi
2025-05-08
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)
Revolution Medicines, Inc.
Phase 3
590
Nagoya, Toyoake-shi, Kashiwa-shi, Matsuyama, Sapporo, Akashi, Kanazawa, Sagamihara
2025-05-06
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
538
Konan-shi, Toyoake-shi, Hachinohe-shi, Chiba, Ichikawa-shi, Fukuoka, Kokuraminami-ku, Kitakyushu-shi, Omuta-shi
2025-02-28
Recruiting
NovoCure GmbH
Phase 3
741
Toyoake-shi, Isehara, Fukuoka, Hokkaido, Ishikawa, Kumamoto, Kyoto, Mitaka
2025-02-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Nagoya, Toyoake-Shi, Gifu, Sapporo, Sendai, Niigata, Iruma-shi, Bunkyō City
2024-12-03
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Showa-Ku, Toyoake-shi, Chiba, Kamogawa-shi, Yoshida-gun, Chikushino-shi, Fukuoka, Koriyama-shi
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
774
Nagoya, Toyoake-shi, Kitakyushu-shi, Sapporo, Nishinomiya-shi, Tsukuba, Kahoku-gun, Kanazawa
2023-09-11
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals
Phase 3
383
Kasugai-Shi, Toyoake-shi, Urayasu-Shi, Sapporo, Kitakyushu, Yokohama, Kashihara, Nara
2023-07-06
Active, closed
Amgen
Phase 3
7,297
Kasugai-shi, Nagoya, Seto-shi, Toyoake-shi, Hirosaki-shi, Asahi-shi, Matsudo-shi, Yoshida-gun
2022-12-14
Active, closed
Biogen
Phase 2/3
450
Nagoya, Toyoake-shi, Aomori, Urayasu-shi, Yoshida-gun, Kitakyushu-shi, Sapporo, Kakogawa-shi
2022-09-13
By invitation
Biogen
Phase 3
864
Nagoya, Toyoake-shi, Chiba, Fukuoka, Kitakyushu-shi, Hiroshima, Sapporo, Himeji-shi
2022-06-10
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Nagoya, Toyoake-shi, Chiba, Urayasu-shi, Kobe, Tsukuba, Kawasaki-shi, Kashihara
2022-04-05
Recruiting
ModernaTX, Inc.
Phase 1/2
50
Toyoake-shi, Sendai
2021-11-09
Active, closed
Biogen
Phase 3
562
Nagoya, Toyoake-shi, Chiba, Narashino-shi, Fukuoka, Kitakyushu-shi, Hiroshima, Sapporo
2021-07-16
Recruiting
ModernaTX, Inc.
Phase 1/2
77
Toyoake-shi, Sendai, Tokyo
2021-04-15
Active, closed
Takeda
Phase 3
354
Toyoake-Shi, Kashiwa-Shi, Matsuyama, Sapporo, Kurume-Shi, Yokohama, Kumamoto, Natori-shi
2020-01-10
Recruiting
Novartis Pharmaceuticals
Observational
700
Nagakute-shi, Toyoake-shi, Chiba, Kurume-shi, Gifu, Sapporo, Kita-gun, Yokohama
2018-09-25
Active, closed
AbbVie
Phase 3
1,336
Nagakute, Nagoya, Toyoake-shi, Abiko-shi, Chiba, Kashiwa-shi, Sakura-shi, Fukuoka
2018-04-09
Recruiting
Phase III Trial of Stage I Ovarian Cancer After Surgery
NCT04063527Epithelial Ovarian Cancer
Japanese Gynecologic Oncology Group
Phase 3
360
Nagakute-shi, Seto-shi, Toyoake-shi, Hirosaki-shi, Kashiwa-shi, Onsen-gun, Fukuoka, Kurume-shi
2012-07-20
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 October 2026. https://priyalifescience.com/clinical-trials-japan/city/toyoake-shi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,493 studies in total at the last sync on 22 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies with a site in Toyoake-shi.

How many clinical trials are recruiting in Toyoake-shi?

13 of the 25 studies on this page are recruiting new participants as of the 22 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Toyoake-shi), 25 studies
PhaseStudiesRecruitingShare
Phase 318872%
Phase 1/23312%
Phase 2/33112%
Observational114%

Most active sponsors

Lead sponsors with the most studies (Toyoake-shi)
Lead sponsorStudiesRecruiting
Biogen41
Amgen32
Bristol-Myers Squibb31
ModernaTX, Inc.22
Novartis Pharmaceuticals21
Otsuka Pharmaceutical Development & Commercialization, Inc.20
Takeda21
AbbVie10
AstraZeneca11
H. Lundbeck A/S10
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.